Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03534271 · ClinicalTrials.gov registry record
The Accuracy of Smartphone Pulse Oximetry in Patients Visiting an Outpatient Pulmonary Function Lab for a 6-Minute Walk Test
A clinical trial, sponsored by Rush University Medical Center.
- Completed
- Registry status
- 47
- Enrollment target
NCT03534271: Completed study, sponsored by Rush University Medical Center.
NCT03534271 is a clinical trial that has completed, run by Rush University Medical Center. The registered enrollment target is 47 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03534271 has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- 47 participants
- Enrollment target
Study Summary
The primary aim of this research is to determine the accuracy of smartphone pulse oximeters in detecting blood oxygen saturations, episodes of desaturations, and heart rate by comparing results to a Masimo© hospital-grade pulse oximeter.
Primary Outcome
Accuracy of smartphone pulse oximeter after 6 minute walk Posttest SpO2 %
Interventions
- DEVICE iPhone with Kenek Edge and Samsung S8
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2018-04-27 |
| Est. Completion | 2019-08-01 |
What the finished NCT03534271 record still lists
NCT03534271 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 47 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which iPhone with Kenek Edge and Samsung S8 is the first listed.
NCT03534271 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03534271 about?
NCT03534271 is a clinical study titled "The Accuracy of Smartphone Pulse Oximetry in Patients Visiting an Outpatient Pulmonary Function Lab for a 6-Minute Walk Test". The primary aim of this research is to determine the accuracy of smartphone pulse oximeters in detecting blood oxygen saturations, episodes of desaturations, and heart rate by comparing results to a Masimo© hospital-grade pulse oximeter.
What is the current status of trial NCT03534271?
This trial is currently completed. The enrollment target is 47 participants. The study started on 2018-04-27. Estimated completion is 2019-08-01.
What interventions are being tested in trial NCT03534271?
The interventions under investigation include: iPhone with Kenek Edge and Samsung S8 (DEVICE).
Who is sponsoring clinical trial NCT03534271?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI